Search results for David Kereiakes

Windham Capital Partners’ David Kereiakes Joins AO Foundation Technology Transfer Board to Translate Surgical Innovation...

David Ferrera on Building What Works in Medical Devices

David Ferrera is a medical device engineer, entrepreneur, and inventor with nearly 30 years of experience in neurovascular and interventional medicine. Read more: David Ferrera on...

Cardio drugmaker Kardigan plans to go public

Founded by former MyoKardia executives, the startup has in mid- to late-stage testing three medicines licensed from the likes of Sanofi, Ionis and Bristol Myers Squibb.

Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadersh...

Medcura Appoints Medical Device Industry Veteran Gary P. Fischetti to Board of Directors

<![CDATA[Modern Communication Between FDA, Biotech, and Investors: Q&A with David Crean]]>

Allogene CEO to step down; Agios drug fails key test

David Chang will leave his post after an eight-year run at the cell therapy maker. Elsewhere, a next-generation blood disease drug stumbled and an acquisition yielded an FDA approv...

<![CDATA[Changing a Cell’s Fate: Q&A with Yerem Yeghiazarians, MD]]>

Eko Health Appoints Dr. Steven Steinhubl as CMO to Drive Cardiac AI and Global Clinical Strategy

What You Should Know Eko Health has appointed Steven R. Steinhubl, MD, a prominent cardiologist and digital medicine pioneer, as its Chief Medical Officer (CMO) and executive leade...

Integra LifeSciences Announces Leadership Transition

Chutes & Ladders—Allogene swaps in CMO as new chief exec

After more than eight years at the helm of off-the-shelf CAR-T company Allogene Therapeutics, co-founder David Chang, M.D., Ph.D., is stepping down so that Zachary Roberts, M.D., P...

Philippe Pouletty, Carvolix

Philippe Pouletty is a physician who’s an inventor, French venture capitalist, and the founder of Carvolix. Carvolix is a medical technology company that is introducing AI into car...

Giants in Obstetrics and Gynecology: A Profile of David M. Gershenson, MD: a pioneer in the diagnosis, characterization,...

David M. Gershenson, MD, Professor of Gynecologic Oncology and Reproductive Medicine and former Chair of that Department at The University of Texas MD Anderson Cancer Center, has b...

Cardiac Device Co. Says Ex-Manager Took Secrets To Rival

Vital Connect Inc., a company that sells wearable cardiac monitoring devices, told a North Carolina federal court that a former senior key accounts manager pilfered its confidentia...

Peytant Solutions Names Tom Douthitt as Chief Executive Officer

Peytant Solutions, the medical technology company that developed the first and only stent covered with human-derived amniotic membrane to receive FDA De Novo granted clearance, tod...

Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadersh...

Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of…

AACR: Former Genentech leader engineers startup with vision for ‘smart’ cancer drugs

Just a few years ago, Daniel Chen, M.D., Ph.D., was spending his days in his backyard, sketching out designs for new antibody-drug conjugates with a friend. Now, he’s sharing with...

BioCardia CEO Peter Altman buys $5,550 in common stock

Stryker names Nick Mead Vice President, Investor Relations

David Leininger Returns to DART

Dallas Area Rapid Transit (DART) on April 16 reported that David Leininger will take the throttle as Interim President and CEO on May 4, 2026, following the departure of Nadine […]...

Cover

Editorial Board

David Stoltzfus Joins Hall Render as a Shareholder

Hall Render is pleased to announce that David Stoltzfus has joined the Firm as a Shareholder in its Washington, D.C. office. Dave is a health care antitrust attorney who advises ho...